CMC Biologics, Trellis sign long-term agreement to advance mAbs
CMC Biologics and Trellis Bioscience have entered into a manufacturing agreement for the process development and production of two of Trellis’ monoclonal antibodies (mAbs).
CMC Biologics and Trellis Bioscience have entered into a manufacturing agreement for the process development and production of two of Trellis’ monoclonal antibodies (mAbs).
Evotec AG has acquired Aptuit for $300m as CRO consolidation continues – bringing innovative products forward faster and at a lower cost, says CEO.
Dr Reddy's says efforts to fix plant problems flagged by US FDA impacted its active pharmaceutical ingredient (API) business in the first quarter of fiscal 2018.
PharPoint Research, Inc. has established a dedicated consulting division as it expands its services in response to growing client demand.
Insilico Medicine and Juvenescence have signed a multi-year drug development agreement to advance compounds discovered using artificial intelligence.